Additionally, TRAP1-negative mice have signs of diminished lifespan, with abnormal tissue generation, dysplasia [83], and cells delivered from such mice with impaired cell proliferation were non-viable [84], thus suggesting that TRAP1 inhibitors have potential as senolytic agents. The gene discussed is TRAP1; the disease is dysplasia.